Drug Type Small molecule drug |
Synonyms ABSK 141, ABSK141 |
Target |
Action inhibitors |
Mechanism KRAS G12D inhibitors(GTPase KRas G12D inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| KRAS G12D mutation Solid Tumors | Phase 2 | China | 20 Mar 2026 | |
| Locally Advanced Malignant Solid Neoplasm | Phase 2 | China | 20 Mar 2026 | |
| Neoplasms | Discovery | China | - |





